Deciphering cellular plasticity in pancreatic cancer for effective treatments

Document Type

Article

Publication Date

3-1-2024

Publication Title

Cancer metastasis reviews

Abstract

Cellular plasticity and therapy resistance are critical features of pancreatic cancer, a highly aggressive and fatal disease. The pancreas, a vital organ that produces digestive enzymes and hormones, is often affected by two main types of cancer: the pre-dominant ductal adenocarcinoma and the less common neuroendocrine tumors. These cancers are difficult to treat due to their complex biology characterized by cellular plasticity leading to therapy resistance. Cellular plasticity refers to the capability of cancer cells to change and adapt to different microenvironments within the body which includes acinar-ductal metaplasia, epithelial to mesenchymal/epigenetic/metabolic plasticity, as well as stemness. This plasticity allows heterogeneity of cancer cells, metastasis, and evasion of host's immune system and develops resistance to radiation, chemotherapy, and targeted therapy. To overcome this resistance, extensive research is ongoing exploring the intrinsic and extrinsic factors through cellular reprogramming, chemosensitization, targeting metabolic, key survival pathways, etc. In this review, we discussed the mechanisms of cellular plasticity involving cellular adaptation and tumor microenvironment and provided a comprehensive understanding of its role in therapy resistance and ways to overcome it.

Medical Subject Headings

Humans; Cell Plasticity; Pancreatic Neoplasms; Pancreas; Cellular Reprogramming; Carcinoma, Pancreatic Ductal; Tumor Microenvironment

PubMed ID

38194153

ePublication

ePub ahead of print

Volume

43

Issue

1

First Page

393

Last Page

408

Find It @ Sladen

Share

COinS